Please login to the form below

Not currently logged in
Email:
Password:

Aptiv

This page shows the latest Aptiv news and features for those working in and with pharma, biotech and healthcare.

Icon boost medical device trial capability with Aptiv acquisition

Icon boost medical device trial capability with Aptiv acquisition. Deal will also enhance the CRO's position inadaptive trials and in Japan. ... Dublin-based contract research organisation Icon has acquired Aptiv Solutions for $143.5m, boosts its

Latest news

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Latest Intelligence

  • Deal Watch table for April 2014 Deal Watch table for April 2014

    Aptiv Solutions/ ICON. Acquisition. CRO/ Adaptive Clinical Trials. 143.5. California Stem Cell/ NeoStem.

  • Pharma deals during April 2014 Pharma deals during April 2014

    Mallinckrodt, Ranbaxy Laboratories/ Sun Pharmaceuticals; Silom Medical Company/ Actavis), Pharmaceuticals/Biologics (Furiex/ Forest Laboratories, Andromeda Biotech/ Hyperion Therapeutics), OTC (Insight Pharmaceuticals/ Prestige Brands), Diagnostics

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Lucid Group Communications Limited

WE’RE ON A MISSION To enhance patients’ lives through communication that changes behaviour and improves patient health outcomes....

Latest intelligence

The gene therapy revolution
Gene therapies are bringing new hope for many people with diseases caused by genetic disorders...
PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...

Infographics